BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15127238)

  • 1. Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis.
    Agarwala SS; Hellstrand K; Gehlsen K; Naredi P
    Cancer Immunol Immunother; 2004 Sep; 53(9):840-1. PubMed ID: 15127238
    [No Abstract]   [Full Text] [Related]  

  • 2. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
    Asemissen AM; Scheibenbogen C; Letsch A; Hellstrand K; Thorén F; Gehlsen K; Schmittel A; Thiel E; Keilholz U
    Clin Cancer Res; 2005 Jan; 11(1):290-7. PubMed ID: 15671558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver resection in multimodal concepts improves survival of metastatic melanoma: a single-centre case-matched control study.
    Hau HM; Tautenhahn HM; Schoenberg MB; Atanasov G; Wiltberger G; Morgül MH; Uhlmann D; Seitz AT; Simon JC; Schmelzle M; Bartels M
    Anticancer Res; 2014 Nov; 34(11):6633-9. PubMed ID: 25368268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy Foundation Symposium XVIII: Session on malignant melanoma.
    Agarwala SS
    Expert Opin Investig Drugs; 2001 Feb; 10(2):381-5. PubMed ID: 11424886
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
    Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
    Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
    [No Abstract]   [Full Text] [Related]  

  • 6. Histamine: a novel approach to cancer immunotherapy.
    Hellstrand K; Brune M; Naredi P; Mellqvist UH; Hansson M; Gehlsen KR; Hermodsson S
    Cancer Invest; 2000; 18(4):347-55. PubMed ID: 10808371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia--background and results.
    Brune M; Romero AI; Hellstrand K
    Inflamm Res; 2009 Apr; 58 Suppl 1():4-8. PubMed ID: 19271134
    [No Abstract]   [Full Text] [Related]  

  • 8. Histamine and cytokine therapy.
    Hellstrand K; Hermodsson S; Naredi P; Mellqvist UH; Brune M
    Acta Oncol; 1998; 37(4):347-53. PubMed ID: 9743456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins.
    Becker JC; Pancook JD; Gillies SD; Mendelsohn J; Reisfeld RA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2702-7. PubMed ID: 8610104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of malignant melanoma at the stage of distant metastasis].
    Garbe C; Eigentler TK
    Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastases.
    Keilholz U; Scheibenbogen C; Brado M; Georgi P; Maclachlan D; Brado B; Hunstein W
    Eur J Cancer; 1994; 30A(1):103-5. PubMed ID: 8142149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
    Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
    [No Abstract]   [Full Text] [Related]  

  • 13. Metastatic melanoma.
    Sun W; Schuchter LM
    Curr Treat Options Oncol; 2001 Jun; 2(3):193-202. PubMed ID: 12057119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse after successful treatment with immunotherapy: lessons for the future.
    Fisher RI
    Cancer J Sci Am; 1998; 4(2):78-9. PubMed ID: 9532407
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of human melanoma hepatic metastases in nude mice with human cytotoxic T lymphocytes.
    Crowley NJ; Vervaert CE; Seigler HF
    Arch Surg; 1991 Apr; 126(4):433-7. PubMed ID: 2009057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine in immunotherapy of advanced melanoma: a pilot study.
    Hellstrand K; Naredi P; Lindner P; Lundholm K; Rudenstam CM; Hermodsson S; Asztély M; Hafström L
    Cancer Immunol Immunother; 1994 Dec; 39(6):416-9. PubMed ID: 8001030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Progression-Free and Overall Survival in Two Melanoma Patients Treated with Patient-Specific Therapeutic Vaccine Eltrapuldencel-T After Resection of a Solitary Liver Metastasis.
    Dillman RO
    Cancer Biother Radiopharm; 2016 Apr; 31(3):71-4. PubMed ID: 27093340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects of immunotherapy of malignant melanoma].
    Enk A
    Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy of melanoma].
    Dummer R; Nestle FO; Burg G
    Dtsch Med Wochenschr; 2000 Oct; 125(41):1240-2. PubMed ID: 11076264
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.